Pharma Journalist -

RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines. Beyond mRNA vaccines, innovative developments are being made using siRNA, microRNA, tRNA and…
Read More...

Quoin Pharmaceuticals Ltd. announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has entered into an exclusive Distribution Agreement with ER-Kim, a partner for…
Read More...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment…
Read More...

Novartis India Limited (NIL) announced an exclusive sales and distribution agreement with Dr. Reddy’s Laboratories (Dr. Reddy’s) for a few of its Established Medicines which includes…
Read More...

Asymchem Laboratories (Tianjin) Co., Ltd. announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a new supply agreement with the government of Colombia for 10.8 million doses…
Read More...

AiCuris Anti-infective Cures AG (AiCuris), a leading company in the discovery and development of drugs against infectious diseases, and Hybridize Therapeutics (Hybridize), focused on…
Read More...

Eli Lilly and Company announced an agreement with the U.S. government to supply up to 600,000 doses of investigational drug bebtelovimab for at least $720 million. The U.S. government…
Read More...

Recently, two companies that have been active in the field of Host Cell Protein (HCP) detection for many years have partnered up to offer their respective methods to biologics…
Read More...

Active Biotech announced it has entered into an exclusive license agreement with Oncode Institute in the Netherlands, for the global rights to patents relating to the use of tasquinimod…
Read More...